Factors and mechanisms of arterial hypertension development in patients with atherosclerosis of lower limb arteries
https://doi.org/10.15829/1728-8800-2019-1-150-155
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The article contains information about the frequency of development of arterial hypertension (AH), the features and causes of its development in patients with peripheral atherosclerosis. AH in patients with chronic atherosclerotic diseases of lower limb arteries and acute thrombotic occlusion complicates the course of this pathology. In most patients, the opinion that AH associated with atherosclerosis due to affection of renal arteries is generally accepted. Currently, an important practical question remains about the possible negative impact of intensive antihypertensive therapy with a significant reduction in blood pressure and aggravation of necrobiosis processes in the ischemic limb in a patient with acute arterial thrombosis.
About the Authors
E. M. Evsikov
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
V. I. Vechorko
O. M. Filatov Municipal Clinical Hospital № 15
Moscow
Moscow
N. V. Teplova
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
M. H. Zhapueva
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
N. G. Artamonova
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
References
1. The TASC Steering Committee. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Endovasc Ther. 2015;22:657-71. https://doi.org/10.1177/1526602815592206.
2. Guidelines on the diagnosis and treatment of periferal artery diseases. Eur Heart J. 2011;32:2851-906. https://doi.org/10.1093/eurheartj/ehr211.
3. Dachun Xu, Jue Li, Liling Zou, et al. Sensitivity and specificity of the anklebrachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 2010;15(5):361-9. https://doi.org/10.1177/1358863X10378376.
4. Da Silva A, Widmer LK, Ziegler HW, et al. The Basle longitudinal study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. J Chronic Dis. 1979;32:797-803. https://doi.org/10.1016/0021-9681(79)90059-6.
5. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45:5-67. https://doi.org/10.1016/j.jvs.2006.12.037.
6. Wong ND, Lopez VA, Allison MA, et al. Abdominal aortic calcium and multisite atherosclerosis. Atherosclerosis. 2011;214(2):436-41. https://doi.org/10.1016/j.atherosclerosis.2010.09.011.
7. Melnikov NV, Zelinsky VA, Apresyan AYu. Predictors and serum markers of abdominal aortic calcification. Regional blood circulation and microcirculation. 2012;44(4):12-7. (In Russ.) http://www.fesmu.ru/elib/Article.aspx?id=275062.
8. Melnikov MV, Zelinsky VA, Zhorina AS, et al. Calcification of the abdominal aorta in peripheral atherosclerosis: risk factors and markers. Atherosclerosis and dyslipidemia. 2014;16(3):33-8. (In Russ.) https://cyberleninka.ru/article/n/kaltsifikatsiya-abdominalnoyaorty-pri-perifericheskom-ateroskleroze-faktory-riska-i-markery.
9. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:584-636. https://doi.org/10.1161/CIR.0b013e3182051b4c.
10. Perrone-Filardi P, Achenbach S, Mohlenkamp S, et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur Heart J. 2011;32:1986-93. https://doi.org/10.1093/eurheartj/ehq235.
11. Evsikov EM, Teplova NV, Maytesyan DA, et al. The nature of hypertension in patients with aortic atherosclerosis with acute thrombotic occlusion syndrome. Kardiologiia. 2017;10:89-91. (In Russ.) https://doi.org/10.15829/1560-4071-2016-9-14-18.
12. Vechorko VI, Teplova NV, Evsikov EM. The frequency and causes of arterial hypertension in patients with acute thrombotic occlusion in atherosclerosis of lower limb arteries. National Congress of Therapists. Moscow, November 21-23, 2018;28- 9. (In Russ.) https://www.rnmot.ru/public/files/events/7/774/Cover_tez_NKT.pdf.
13. Teplova NV, Lyusov VA, Oganov RG, et al. Nephrogenic factors for the formation of resistance to antihypertensive therapy in patients with primary arterial hypertension. Rational Pharmacotherapy in Cardiology. 2015;6:590-4. (In Russ.). https://doi.org/10.20996/1819-6446-2015-11-6-590-594.
14. Evsikov EM, Teplova NV, Sharipov RA, et al. The nature of the pathology of the kidneys in patients with arterial hypertension resistant to therapy course. Collection of theses of the X National Congress of Physicians. 2015; 62. (In Russ.) https://congress.rnmot.ru/public/files/events/2/261/Cover_tez_NKT.pdf.
15. Teplova NV. Resistant forms of primary arterial hypertension. A guide for doctors. Ed. Litterra. M. 2016;110 p. (In Russ.) ISBN 978-5-4235-0237-9.
16. Teplova NV, Lyusov VA, Oganov RG, et al. Resistance to antihypertensive therapy in patients with hypertension. The value of renal and hemodynamic factors. Ural Medical J. 2015;10:126-32. (In Russ.) http://www.urmj.ru/archive/2015/85.
17. Teplova NV, Evsikov EM, Zhapueva MKh. Condition of hormonal function and form of thyroid gland pathology in patients with primary arterial hypertension and resistance to antihypertensive therapy. Collection of theses of the Russian National Congress of Cardiology “Russian Cardiological Society in the year of the fight against cardiovascular diseases in Russia” 2015. P.611. (In Russ.) http://scardio.ru/content/activities/2015/Tezisy_moscow_2015.pdf.
18. Bates MC, Campbell JE, Stone et al. Factors affecting long-term survival following renal artery stenting. Catheter Cardiovasc Interv. 2007;69:1037-43. https://doi.org/10.1002/ccd.21121.
19. Agel RA, Zoghbi GJ, Baldwin SA, et al. Prevalence of renal artery stenosis in highrisk veterans referred to cardiac catheterization. J Hypertens. 2003;21:1157-62. https://doi.org/10.1097/01.hjh.0000059047.65882.00.
Review
For citations:
Evsikov E.M., Vechorko V.I., Teplova N.V., Zhapueva M.H., Artamonova N.G. Factors and mechanisms of arterial hypertension development in patients with atherosclerosis of lower limb arteries. Cardiovascular Therapy and Prevention. 2019;18(1):150-155. (In Russ.) https://doi.org/10.15829/1728-8800-2019-1-150-155
Views:
2553
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
